Figure 2.

COVID-19 and Cardiac phenotypes. Patients with acute ST-elevation myocardial infarction (STEMI) requiring intubation should be intubated prior to arrival to the catheterization laboratory. If no dedicated catheterization laboratory is available, thrombolysis should be considered. Patients with severe cardiac phenotypes should be admitted to the coronary care unit (CCU) for close monitoring, and should be considered for ECMO support as well as referred to the cath lab for an invasive strategy or surgery. High risk patients with non-severe cardiac phenotypes should be hospitalized at the very least. Low risk patients with non-severe cardiac phenotypes should be discharged for self-isolation and followed up closely with telehealth platforms.